Literature DB >> 3589765

Alkalemia-associated morbidity and mortality in medical and surgical patients.

L E Anderson, W L Henrich.   

Abstract

The difference in death rate among medical and surgical inpatients having alkalemia is incompletely defined. This prospective study was done to identify the incidence, mortality, and clinical factors that resulted in a poor outcome in both groups of patients. We screened a total of 10,811 consecutive arterial blood gas values; in 4,427 (40.9%) the pH was greater than 7.44, and in 2,577 (23.8%) the pH was greater than 7.48. The study group consisted of 409 patients (213 medical, 196 surgical) whose pH value was greater than 7.48; 253 of these patients (61.9%) had pure respiratory alkalosis, 120 (29.3%) had mixed respiratory and metabolic alkalosis, 27 (6.6%) had a mixed acid base disorder, and nine (2.2%) had pure metabolic alkalosis. Overall group mortality was 27.9% and increased as pH values rose, reaching 48.5% when the pH was greater than 7.60. The overall mortality among medical patients (36.6%) exceeded that among the surgical patients (12.4%) (P less than .05), an observation that applied over a wide range of pH values. Patients having mixed respiratory and metabolic alkalosis had a significantly poorer outcome (44.2% mortality) than the alkalemic group as a whole (27.9% mortality) (P less than .05). Alkalemia-associated illnesses are common in hospitalized patients and are associated with high mortality in both medical and surgical patients, though the death rate is higher among medical patients. Mixed respiratory and metabolic alkalosis appears to be associated with a particularly poor prognosis.

Entities:  

Mesh:

Year:  1987        PMID: 3589765     DOI: 10.1097/00007611-198706000-00016

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  23 in total

Review 1.  [Stewart's acid-base approach].

Authors:  Georg-Christian Funk
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

Review 2.  A Literature Review of the Use of Sodium Bicarbonate for the Treatment of QRS Widening.

Authors:  Rebecca E Bruccoleri; Michele M Burns
Journal:  J Med Toxicol       Date:  2016-03

3.  Respiratory clinics ventilatory management in a patient with chronic obstructive pulmonary disease: a need for caution.

Authors:  R Khajotia
Journal:  Malays Fam Physician       Date:  2008-12-31

4.  Severe metabolic alkalosis in pregnancy.

Authors:  Charlotte Frise; Muna Noori; Catherine Williamson
Journal:  Obstet Med       Date:  2013-07-23

5.  Rising serum sodium levels are associated with a concurrent development of metabolic alkalosis in critically ill patients.

Authors:  Gregor Lindner; Christoph Schwarz; Heidelinde Grüssing; Nikolaus Kneidinger; Andreas Fazekas; Georg-Christian Funk
Journal:  Intensive Care Med       Date:  2012-11-17       Impact factor: 17.440

6.  Severe Respiratory Alkalosis in Acute Ischemic Stroke: A Rare Presentation.

Authors:  Vijayadershan Muppidi; Sashank Kolli; Vasuki Dandu; Samata Pathireddy; Sreenath Meegada
Journal:  Cureus       Date:  2020-04-20

Review 7.  Drug-induced acid-base disorders.

Authors:  Daniel Kitterer; Matthias Schwab; M Dominik Alscher; Niko Braun; Joerg Latus
Journal:  Pediatr Nephrol       Date:  2014-11-05       Impact factor: 3.714

8.  Extreme metabolic alkalosis in intensive care.

Authors:  Swagata Tripathy
Journal:  Indian J Crit Care Med       Date:  2009-10

9.  [Metabolic alkalosis despite hyperlactatemia and hypercapnia. Interpretation and therapy with help of the Stewart concept].

Authors:  D Chappell; K Hofmann-Kiefer; M Jacob; P Conzen; M Rehm
Journal:  Anaesthesist       Date:  2008-02       Impact factor: 1.041

10.  Bicarbonate Concentration, Acid-Base Status, and Mortality in the Health, Aging, and Body Composition Study.

Authors:  Kalani L Raphael; Rachel A Murphy; Michael G Shlipak; Suzanne Satterfield; Hunter K Huston; Anthony Sebastian; Deborah E Sellmeyer; Kushang V Patel; Anne B Newman; Mark J Sarnak; Joachim H Ix; Linda F Fried
Journal:  Clin J Am Soc Nephrol       Date:  2016-01-14       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.